What does Bafna Pharma. do?
Bafna Pharmaceuticals Ltd manufactures pharmaceutical formulations, focusing on Betalactum and Non Betalactum products. Established in 1981, it operates as a micro-cap company with a market cap of Rs 176 Cr and reported net sales of 39 Cr and a net profit of 1 Cr for the quarter ending March 2025.
Overview:Bafna Pharmaceuticals Ltd is engaged in the manufacturing of pharmaceutical formulations, specializing in both Betalactum and Non Betalactum products, and operates within the Pharmaceuticals & Biotechnology industry as a Micro Cap company.History:
Bafna Pharmaceuticals Ltd was established in 1981 by Mr. Bafna Mahaveer Chand. The company initially operated as a proprietary concern and set up its first manufacturing unit in Madhavaram (Chennai) in October 1984. The latest financial results reported are for the quarter ending March 2025, showing net sales and profit figures.
Financial Snapshot:
- Net Sales: 39 Cr (Quarterly Results - Mar 2025)
- Net Profit: 1 Cr (Quarterly Results - Mar 2025)
- Market Cap: Rs 176 Cr (Micro Cap)
Key Metrics:
- P/E: 28.00
- Industry P/E: 35
- Dividend Yield: 0.00%
- Debt Equity: 0.21
- Return on Equity: 7.63%
- Price to Book: 2.13
Contact Details:
Address: Bafna Towers New No 68, Old No 299 Thambu Chetty St Chennai Tamil Nadu : 600001
Tel: 91-44-25267517/25270992/4267755
Email: info@bafnapharma.com
Website: http://www.bafnapharma.com
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
